Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022)

Healthy Extracts (HYEX) reported Capital Expenditures of $7987.0 for Q1 2022, down 65.25% quarter-over-quarter from $22985.0 in Q1 2019.

Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022) Analysis & Trends

Healthy Extracts has reported Capital Expenditures for 2 years, with the latest figure at $7987.0 in Q1 2022.

For the quarter ending Q1 2022, Capital Expenditures changed N/A year-over-year to $7987.0; the trailing twelve-month figure through Dec 2022 stood at $7987.0 (changed N/A YoY), and the FY2025 full-year result was $19302.0, changed N/A from the prior year.
Capital Expenditures for Q1 2022 stood at $7987.0, down from $22985.0 in the prior quarter.
The five-year high for Capital Expenditures was $22985.0 in Q1 2019, with the low at $7987.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	168.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	110.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	100.80 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	9.10 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	51.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	4.09 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	8.83 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	2.04 Mn
10	Healthy Extracts	-	-	957,429.00	-

Download Data